台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效

佳醫

(4104)
可現股當沖
  • 股價
    90.8
  • 漲跌
    ▼0.5
  • 漲幅
    -0.55%
  • 成交量
    111
  • 產業
    上市 生技醫療類股
  • 331人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
佳醫 (4104)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/23 ~ 2024/04/30     後一日»

券商獲利排行 - 2024/04/23 ~ 2024/04/30

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.20%152.32.8149.5-131713891.991.591.990.8
  0.97%36.634.81.8-1404192.291.792.690.8
  0.74%32.6032.6-4804891.5091.590.8
  1.47%31.1031.1-2202392.292.692.290.8
  0.68%28.8-2.231-4244691.692.191.590.8
  1.46%28.2028.2-2002192.192.392.190.8
  1.12%21.6021.6-2102191.891.891.890.8
  1.29%13.10.912.2-911191.991.29290.8
  0.68%12.50.212.3-1912091.491.291.490.8
  2.10%11.70.711-51692.992.39390.8
  0.66%10.90.210.7-1711891.491.291.490.8
  1.05%9.76.43.3-181092.191.692.490.8
  1.14%9.409.4-80991.891.791.890.8
  1.28%9.418.4-71891.9919290.8
  1.92%8.91.27.7-31592.591.592.790.8
  0.08%8.318.1-9.81011110191.991.89290.8
  0.90%8.32.26.1-451091.991.69290.8
  1.26%8.11.76.4-52791.991.392.190.8
  1.24%808-60791.99191.990.8
  1.69%7.807.8-50592.4092.490.8
  1.63%7.507.5-40592.391.692.390.8
  0.49%6.8-0.27-961591.691.691.690.8
  1.02%6.615.6-42791.891.491.990.8
  0.78%6.40.55.9-72991.691.491.790.8
  0.96%6.20.26-51791.891.691.890.8
  0.63%5.8-0.56.3-811091.59291.590.8
  1.23%5.705.7-50591.9091.990.8
  0.88%4.95.5-0.71659291.592.690.8
  0.88%4.93.41.5-1569291.692.390.8
  0.34%4.7-0.65.3-1221591.291.591.290.8
  1.63%4.504.5-30392.3092.390.8
  1.59%4.404.4-30392.3092.390.8
  0.89%4.1-0.24.3-41591.992.191.990.8
  0.89%4.104.1-50591.691.891.690.8
  0.74%40.43.6-51691.591.191.590.8
  1.45%404-20392.192.292.190.8
  1.01%3.703.7-40491.7091.790.8
  1.01%3.703.7-40491.7091.790.8
  0.33%3.6-1.34.9-1021291.491.991.390.8
  1.30%3.603.6-3039209290.8
  1.30%3.603.6-3039209290.8
  0.56%3.603.6-60791.391.591.390.8
  1.85%3.403.4-20292.5092.590.8
  1.84%3.403.4-10292.591.792.590.8
  0.91%3.303.3-40491.691.691.690.8
  1.78%3.303.3-20292.5092.590.8
  1.14%3.103.1-30391.891.891.890.8
  1.56%2.902.9-20292.291.892.290.8
  0.61%2.80.22.6-22591.791.691.790.8
  1.52%2.802.8-10292.191.392.290.8

券商虧損排行 - 2024/04/23 ~ 2024/04/30

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.12%-88.7-10.1-78.65886279292.191.890.8
  -0.78%-87.3-0.4-86.9921223091.791.791.790.8
  -1.24%-46.90-46.94141091.991.992.590.8
  -0.66%-32.7-22.6-10.18544691.892.191.690.8
  -1.71%-23.5-23.500151591.992.691.190.8
  -0.59%-17.4-1-16.418321491.791.791.690.8
  -0.78%-16.7-12.7-42232192.592.892.290.8
  -1.34%-16.1-0.1-161213192.192.19290.8
  -1.08%-12.9-0.2-12.71213191.891.991.790.8
  -1.44%-11.90-11.999092.192.1090.8
  -1.18%-11.90-11.91111091.991.9090.8
  -0.56%-10.71.3-121621591.691.591.890.8
  -1.14%-10.5-3.9-6.6510591.992.191.490.8
  -0.77%-9.20-9.21313091.591.5090.8
  -1.90%-8.8-0.7-8.145192.792.892.190.8
  -1.73%-80-855092.492.4090.8
  -1.41%-7.80-7.866092.192.1090.8
  -0.97%-6.20-6.277091.791.7090.8
  -1.30%-60-65509292090.8
  -1.29%-5.9-1.7-4.225291.992.291.390.8
  -1.25%-5.70-5.755091.991.992.290.8
  -0.76%-5.60-5.688091.591.5090.8
  -1.49%-5.50-5.544092.292.292.590.8
  -0.49%-5.40-5.41212091.391.3090.8
  -1.38%-5.10-5.144092.192.1090.8
  -1.07%-4.90-4.955091.891.8090.8
  -1.18%-4.30-4.344091.991.991.890.8
  -1.15%-4.20-4.244091.991.9090.8
  -0.62%-3.9-0.3-3.757291.591.591.490.8
  -1.07%-3.90-3.944091.891.8090.8
  -1.06%-3.9-2.3-1.614392.192.491.690.8
  -2.10%-3.90-3.922092.892.8090.8
  -0.61%-3.90.1-457291.691.691.790.8
  -1.34%-3.70-3.73309292090.8
  -1.32%-3.60-3.6330929292.390.8
  -1.30%-3.60-3.63309292090.8
  -1.27%-3.50-3.5330929292.890.8
  -0.38%-3.51.4-5910191.591.492.890.8
  -0.77%-3.5-0.9-2.635291.591.791.290.8
  -0.77%-3.50-3.555091.591.5090.8
  -0.77%-3.50-3.555091.591.5090.8
  -0.93%-3.40-3.444091.791.7090.8
  -1.23%-3.4-0.9-2.513191.892.191.290.8
  -1.79%-3.30-3.322092.592.5090.8
  -0.90%-3.30-3.334091.691.691.590.8
  -1.18%-3.3-0.5-2.823192.192.291.790.8
  -1.73%-3.20-3.222092.492.4090.8
  -0.56%-30-366091.391.3090.8
  -0.65%-30.3-3.335291.991.992.190.8
  -1.09%-30-333091.891.8090.8
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音